Understanding Symptom Recognition and Treatment Decision-making in Hispanic/Latino Lung Cancer Patients
This study is currently recruiting participants.
Verified March 2013 by Memorial Sloan-Kettering Cancer Center
Sponsor:
Memorial Sloan-Kettering Cancer Center
Collaborators:
The Sophie Davis School of Biomedical Education The City College of New York
CUNY
Information provided by (Responsible Party):
Memorial Sloan-Kettering Cancer Center
ClinicalTrials.gov Identifier:
NCT01466946
First received: November 4, 2011
Last updated: March 11, 2013
Last verified: March 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of the study is to understand why Hispanic/Latino patients with lung cancer are diagnosed later than other groups.
| Condition | Intervention |
|---|---|
|
Lung Cancer |
Behavioral: semi-structured interviews |
| Study Type: | Observational |
| Study Design: | Observational Model: Case-Only Time Perspective: Prospective |
| Official Title: | Understanding Symptom Recognition and Treatment Decision-making in Hispanic/Latino Lung Cancer Patients |
Resource links provided by NLM:
Further study details as provided by Memorial Sloan-Kettering Cancer Center:
Primary Outcome Measures:
- psychosocial issues [ Time Frame: 2 years ] [ Designated as safety issue: No ]related to lung cancer symptom recognition, delays in lung cancer diagnosis of Hispanic/Latino patients and treatment decision-making processes.
- cultural issues [ Time Frame: 2 years ] [ Designated as safety issue: No ]related to lung cancer symptom recognition, delays in lung cancer diagnosis of Hispanic/Latino patients and treatment decision-making processes.
Secondary Outcome Measures:
- identify obstacles [ Time Frame: 2 years ] [ Designated as safety issue: No ]that have been overcome by Hispanic/Latino lung cancer patients who have succeeded in obtaining access to care at an NCI-designated cancer center, and probe for barriers that these individuals believe still need to be addressed or that they were not successful in surpassing.
| Estimated Enrollment: | 24 |
| Study Start Date: | November 2011 |
| Estimated Study Completion Date: | November 2013 |
| Estimated Primary Completion Date: | November 2013 (Final data collection date for primary outcome measure) |
| Groups/Cohorts | Assigned Interventions |
|---|---|
|
semi-structured interviews
A qualitative study of MSKCC lung cancer patients of Hispanic/Latino descent by collecting retrospective patient narratives to understand the processes that led them to seek medical help when they did, their experiences in seeking and receiving medical guidance, as well as their decisions regarding lung cancer treatment. In addition, we will explore how these patients' representations of lung cancer with its associated risk factors and symptoms affected their treatment decisions.
|
Behavioral: semi-structured interviews
Use semi-structured interview methods to gather narrative data from research participants, as more open-ended interviews allow participants to share information that is most relevant to their own experiences (Patton, 2002; Rubin & Rubin, 2005; Kvale, 1996). Semi-structured interviewing can generate a rich understanding of a participant's life routines, experiences, and attitudes related to a topic of inquiry, and can yield a nuanced and thorough description of a research participant's life story and belief systems.
|
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Study Population
Self-identified Hispanic/Latino patients with biopsy-proven primary lung cancer treated at MSKCC.
Criteria
Inclusion Criteria:
- Self-identified Hispanic/Latino patients with biopsy-proven primary lung cancer treated at MSKCC, including stages of disease I-IV
- 18 years of age or older
- Fluent in English or Spanish
- Patients must reside in the U.S
Exclusion Criteria:
- Spanish-surnamed patients who do not self identify as Hispanic/Latino (e.g., Philippines-born individuals)
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01466946
Contacts
| Contact: William Alago, MD | 212-639-2235 | |
| Contact: Nabil Rizk, MD | 212-639-8357 |
Locations
| United States, New York | |
| Memorial Sloan Kettering Cancer Center | Recruiting |
| New York, New York, United States, 10065 | |
| Contact: William Alago, MD 212-639-2235 | |
| Contact: Nabil Rizk, MD 212-639-8357 | |
| Principal Investigator: William Alago, MD | |
Sponsors and Collaborators
Memorial Sloan-Kettering Cancer Center
The Sophie Davis School of Biomedical Education The City College of New York
CUNY
Investigators
| Principal Investigator: | William Alago, MD | Memorial Sloan-Kettering Cancer Center |
More Information
Additional Information:
No publications provided
| Responsible Party: | Memorial Sloan-Kettering Cancer Center |
| ClinicalTrials.gov Identifier: | NCT01466946 History of Changes |
| Other Study ID Numbers: | 11-109 |
| Study First Received: | November 4, 2011 |
| Last Updated: | March 11, 2013 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Memorial Sloan-Kettering Cancer Center:
|
lung cancer Hispanic/Latino patients interviews 11-109 |
Additional relevant MeSH terms:
|
Lung Neoplasms Respiratory Tract Neoplasms Thoracic Neoplasms Neoplasms by Site |
Neoplasms Lung Diseases Respiratory Tract Diseases |
ClinicalTrials.gov processed this record on June 18, 2013